Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clare Oliver-Williams

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Circulation. Cardiovascular Quality and Outcomes|June 20, 2023
Impact of a Prior Cancer Diagnosis on Quality of Care and Survival Following Acute Myocardial Infarction: Retrospective Population-Based Cohort Study in EnglandLucy Teece, Michael J Sweeting, Marlous Hall, et al.
JAMA|August 29, 2017
Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular RiskBrian A Ference, John J P Kastelein, Henry N Ginsberg, et al.
European Heart Journal. Acute Cardiovascular Care|March 8, 2023
Acute heart failure presentation, management, and outcomes in cancer patients: a national longitudinal studyBriana Coles, Catherine A Welch, Rishabh S Motiwale, et al.
JAMA|January 30, 2019
Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart DiseaseBrian A Ference, John J P Kastelein, Kausik K Ray, et al.
Heart (British Cardiac Society)|May 19, 2021
Risks and benefits of percutaneous coronary intervention in spontaneous coronary artery dissectionDeevia Kotecha, Marcos Garcia-Guimaraes, Diluka Premawardhana, et al.
Plos Biology|March 7, 2020
Correction: Lipoprotein signatures of cholesteryl ester transfer protein and HMG-CoA reductase inhibitionJohannes Kettunen, Michael V Holmes, Elias Allara, et al.
Plos Biology|December 21, 2019
Lipoprotein signatures of cholesteryl ester transfer protein and HMG-CoA reductase inhibitionJohannes Kettunen, Michael V Holmes, Elias Allara, et al.
The Lancet. Planetary Health|November 14, 2024
Bridging the gender, climate, and health gap: the road to COP29Kim Robin van Daalen, Laura Jung, Sara Dada, et al.
Nature Communications|March 7, 2019
Assessing the causal association of glycine with risk of cardio-metabolic diseasesLaura B L Wittemans, Luca A Lotta, Clare Oliver-Williams, et al.
Circulation|December 8, 2018
Metabolomic consequences of genetic inhibition of PCSK9 compared with statin treatmentEeva Sliz, Johannes Kettunen, Michael V Holmes, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Circulation. Cardiovascular Quality and Outcomes|June 20, 2023
Impact of a Prior Cancer Diagnosis on Quality of Care and Survival Following Acute Myocardial Infarction: Retrospective Population-Based Cohort Study in EnglandLucy Teece, Michael J Sweeting, Marlous Hall, et al.
JAMA|August 29, 2017
Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular RiskBrian A Ference, John J P Kastelein, Henry N Ginsberg, et al.
European Heart Journal. Acute Cardiovascular Care|March 8, 2023
Acute heart failure presentation, management, and outcomes in cancer patients: a national longitudinal studyBriana Coles, Catherine A Welch, Rishabh S Motiwale, et al.
JAMA|January 30, 2019
Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart DiseaseBrian A Ference, John J P Kastelein, Kausik K Ray, et al.
Heart (British Cardiac Society)|May 19, 2021
Risks and benefits of percutaneous coronary intervention in spontaneous coronary artery dissectionDeevia Kotecha, Marcos Garcia-Guimaraes, Diluka Premawardhana, et al.
Plos Biology|March 7, 2020
Correction: Lipoprotein signatures of cholesteryl ester transfer protein and HMG-CoA reductase inhibitionJohannes Kettunen, Michael V Holmes, Elias Allara, et al.
Plos Biology|December 21, 2019
Lipoprotein signatures of cholesteryl ester transfer protein and HMG-CoA reductase inhibitionJohannes Kettunen, Michael V Holmes, Elias Allara, et al.
The Lancet. Planetary Health|November 14, 2024
Bridging the gender, climate, and health gap: the road to COP29Kim Robin van Daalen, Laura Jung, Sara Dada, et al.
Nature Communications|March 7, 2019
Assessing the causal association of glycine with risk of cardio-metabolic diseasesLaura B L Wittemans, Luca A Lotta, Clare Oliver-Williams, et al.
Circulation|December 8, 2018
Metabolomic consequences of genetic inhibition of PCSK9 compared with statin treatmentEeva Sliz, Johannes Kettunen, Michael V Holmes, et al.
Pageof 5